Dublin, Nov. 20, 2017 -- The "Compression Therapy Market Outlook 2017-2022" report has been added to Research and Markets' offering.
The future of the continuously evolving compression therapy market is determined by several macroeconomic factors, such as political and legal, economic, social, environmental and technological. In the social field, for example, the growing demand is supported by the high prevalence of cancer and other medical conditions, such as cardiovascular diseases (CVDs) which are very often driven by higher workforce participation resulting in unhealthy diets.
In the political sphere, uncertainty surrounding healthcare policies and cuts to healthcare budgets in some countries could negatively affect development of the compression therapy market, while the movement from a pay-for-service to a pay-for-performance model is likely to lead to improved delivery of high quality compression therapy.
This report will examine these factors in more detail to determine the effect they may have on market growth. Examples of CVDs prevention policies, as well as examples of emerging smart textile sensor technologies applicable to compression products that are expected to facilitate sector growth, will be presented. While social highlights will show a clear picture of the market prospects, including a forecast of diabetes prevalence.
Key Topics Covered:
1 Executive summary
2 Driving forces shaping the compression therapy market in 2017-2022
3 Political factors impacting the compression therapy market
4 The economic dynamics of the compression therapy market
5 Social factors in the compression therapy market
6 Technological forces in the compression therapy market
7 Legal factors in the compression therapy market
8 Environmental factors in the compression therapy market
9 Sources
Companies Mentioned
- 3M
- Advanced Therapeutic Materials
- Aleris
- Ames Walker International
- BiaCare Corp
- BSM Medical
- Compression Kinetics
- Covidien plc
- Derma Sciences
- DJO Inc
- Elastic Therapy Inc
- Getting Group
- Integra LifeSciences
- Legs 4 Life
- Medtronic plc
- Orthotic Composites
- sur
- Proxima
- Salzmann Group
- Secant Medical
- Semfinder
- Sigvaris Group
- TeamOlmed
- Therapeutic Support Systems
- Thuasne Group
- Venosan North America
- Wright Therapy Products
For more information about this report visit https://www.researchandmarkets.com/research/jfmpf8/compression
About Research and Markets
Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
CONTACT: Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Cardiovascular Devices


Nasdaq Proposes Fast-Track Rule to Accelerate Index Inclusion for Major New Listings
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million
AMD Shares Slide Despite Earnings Beat as Cautious Revenue Outlook Weighs on Stock
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch
Australian Scandium Project Backed by Richard Friedland Poised to Support U.S. Critical Minerals Stockpile
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering
Instagram Outage Disrupts Thousands of U.S. Users
SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO
FDA Targets Hims & Hers Over $49 Weight-Loss Pill, Raising Legal and Safety Concerns
Nvidia Nears $20 Billion OpenAI Investment as AI Funding Race Intensifies
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine
Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026
TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment
CK Hutchison Launches Arbitration After Panama Court Revokes Canal Port Licences 



